Senior Staff Physician. Director, Residency Training Program. Clinical Professor, Wayne State University School of Medicine.
Radiation Oncology
Dr. Mohamed A. Elshaikh, MD
|
|
Give Review
Doctor Mohamed A. Elshaikh, MD practices Radiation Oncology. He received awards:"CMS Meaningful Use Stage 1 Certification". Mohamed A. Elshaikh, MD is a published doctor. He published 52 publications, including: 'Enhancement of tumor radioresponse in vivo by gemcitabine.' Mohamed Elshaikh accepts all Medicare patients.
Publications
- Adjuvant therapy of uterine clear cell carcinoma: a review.
- Impact of adjuvant chemotherapy and pelvic radiation on pattern of recurrence and outcome in stage I non-invasive uterine papillary serous carcinoma. A multi-instituti...
- The prognostic significance of histologic type in early stage cervical cancer - A multi-institutional study.
- Evaluating organ delineation, dose calculation and daily localization in an open-MRI simulation workflow for prostate cancer patients.
- An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy.
- Significance of lymphovascular space invasion in uterine serous carcinoma: what matters more; extent or presence?
- Recurrence patterns and survival endpoints in women with stage II uterine endometrioid carcinoma: A multi-institution study.
- A novel approach for evaluation of prostate deformation and associated dosimetric implications in IGRT of the prostate.
- Prospective randomized phase 2 trial of intensity modulated radiation therapy with or without oncolytic adenovirus-mediated cytotoxic gene therapy in intermediate-risk...
- Improved survival endpoints with adjuvant radiation treatment in patients with high-risk early-stage endometrial carcinoma.
- Oropharyngeal Carcinoma in Young Adults: An Alarming National Trend.
- Interval Between Hysterectomy and Start of Radiation Treatment Is Predictive of Recurrence in Patients With Endometrial Carcinoma.
- Improved Survival of Baby Boomer Women with Early-stage Uterine Cancer: A Surveillance, Epidemiology and End Results (SEER) Study.
- Is the Two-Tier Ovarian Serous Carcinoma Grading System Potentially Useful in Stratifying Uterine Serous Carcinoma? A Large Multi-Institutional Analysis.
- Impact of Age-Adjusted Charlson Comorbidity Score on Outcomes for Patients with Early-Stage Endometrial Cancer.
- Vaginal cuff dehiscence after vaginal cuff brachytherapy for uterine cancer. A case report.
- Evaluation of multiple image-based modalities for image-guided radiation therapy (IGRT) of prostate carcinoma: A prospective study.
- The impact of race on outcomes of patients with early stage uterine endometrioid carcinoma.
- Endometrial carcinoma in the baby boomer generation. Tumor characteristics and clinical outcome.
- Clinical outcomes of adjuvant chemotherapy and vaginal brachytherapy with or without pelvic radiation for surgical stage I-II uterine serous carcinoma.
- Is Time to Recurrence after Hysterectomy Predictive of Survival in Patients with Early Stage Endometrial Carcinoma?
- Mucinous adenocarcinoma of the endometrium: case series and review of the literature.
- The Prognostic Significance of Age in Surgically Staged Patients with Type II Endometrial Carcinoma.
- Trends in the Utilization of Adjuvant Vaginal Cuff Brachytherapy and/or External Beam Radiation Treatment in Stage I and II Endometrial Cancer: A Surveillance, Epidemi...
- Hysterectomy for uterine adenocarcinoma in the elderly: tumor characteristics, and long-term outcome.
- Feasibility of adenovirus-mediated hNIS gene transfer and 131I radioiodine therapy as a definitive treatment for localized prostate cancer.
- The impact of race on survival in uterine serous carcinoma: a hospital-based study.
- Impact of marital status on survival among women with invasive cervical cancer: analysis of population-based surveillance, epidemiology, and end results data.
- Clinical outcome of pathologic Stage IIA endometrial adenocarcinoma after intravaginal brachytherapy alone.
- Impact of brachytherapy on regional, racial, marital status, and age-related patterns of definitive treatment for clinically localized prostate carcinoma.
- Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomize...
- PSA bounce predicts early success in patients with permanent iodine-125 prostate implant.
- Improvement in relapse-free survival throughout the PSA era in patients with localized prostate cancer treated with definitive radiotherapy: year of treatment an indep...
- Effect of anatomic, procedural, and dosimetric variables on urinary retention after permanent iodine-125 prostate brachytherapy.
- Gliomatosis cerebri: treatment results with radiotherapy alone.
- Recurrent head-and-neck chemodectomas: a comparison of surgical and radiotherapeutic results.
- Vaginal recurrence more than 17 years after hysterectomy and adjuvant treatment for uterine carcinoma with successful salvage brachytherapy: a case report.
- Factors affecting recurrence rates after prostatectomy or radiotherapy in localized prostate carcinoma patients with biopsy Gleason score 8 or above.
- Adjuvant radiation treatment after prostatectomy. Where do we stand?
- Matched case-control study of quality of life and xerostomia after intensity-modulated radiotherapy or standard radiotherapy for head-and-neck cancer: initial report.
- Advances in radiation oncology.
- Comparison of biochemical failure definitions for permanent prostate brachytherapy.
- Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation.
- Acceleration of hyperfractionated chemoradiation regimen for advanced head and neck cancer.
- Phase I study of noninvasive imaging of adenovirus-mediated gene expression in the human prostate.
- Androgen deprivation therapy for patients with prostate carcinoma and Parkinson''s disease: case report and review of literature.
- Radiotherapy: what can be achieved by technical improvements in dose delivery?
- Comparison of the efficacy of local therapies for localized prostate cancer in the prostate-specific antigen era: a large single-institution experience with radical pr...
- Enhancement of tumor radioresponse in vivo by gemcitabine.
- Maximizing therapeutic gain with gemcitabine and fractionated radiation.
- Impact of biochemical failure on overall survival after radiation therapy for localized prostate cancer in the PSA era.
Schools
Ain Shams University Faculty Of Medicine
Cleveland Clin
Doctors Specialties
- Radiation Oncology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Cleveland Clinic Foundation -
Ain Shams University Faculty of Medicine
Hospital
-
Henry Ford Hospital
Drug Facts
| NPI NUMBER | 1861401622 | |
| NPPES Provider LastName | ELSHAIKH | |
| NPPES Provider FirstName | MOHAMED | |
| NPPES Provider ZIPCode | 48202 | |
| NPPES Provider State | MI | |
| Specialty Description | Radiation Oncology | |
| Total Claim Count | 38.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1861401622 |
| Last Name Of The Provider | ELSHAIKH |
| First Name Of The Provider | MOHAMED |
| View All |
Similar Doctors
|
Dr. Michael M. Dominello, DO |
|
|
Dr. Darrel L. Ross, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nejat H. Akbiyik, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rohan L. Deraniyagala, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Newton J. Hurst Jr., MD |
|
|
Dr. Abhirami Hallock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lauren M. Tait, MD |
|
Dr. M S. Siddiqui, MD |
|
|
Dr. Raphael Yechieli, MD
This Doctor is OpenDoctor Recommended.
|